<DOC>
	<DOCNO>NCT01398969</DOCNO>
	<brief_summary>The goal study determine outcome patient recurrent CDI treat fresh HBT versus frozen-and-thawed HBT randomize control trial . The specific objective evaluate safety type HBT compare clinical response , treatment failure relapse rate patient treat fresh HBT compare treat frozen-and-thawed HBT ; also assess functional health well-being patient arm use validated tool . The metagenomics also conduct stool sample collect select patient arm : pre post treatment match donor . The metagenomics data use determine bacteria may contribute cure CDI .</brief_summary>
	<brief_title>Multi-Centre Trial Fresh vs. Frozen-and-Thawed HBT ( Fecal Transplant ) Recurrent CDI</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<criteria>Patient inclusion criterion 1 . Age 18 year old . 2 . Able provide inform consent . 3 . Laboratory pathology : confirm diagnosis recurrent CDI symptom ( define ) within previous 180 day . 4 . ≥ 2 episode CDI within 6 month and/or ongoing symptom consistent CDI despite treatment oral vancomycin dose least 125 mg 4 time daily least 5 day . Symptoms CDI , diarrhea deﬁned : 3 unformed bowel movement 24 hour minimum 2 day cause diarrhea . Subjects require laboratory pathologyconfirmed diagnosis recurrent C. difficile infection recurrence deﬁned return diarrhea positive stool test period symptom resolution within 8 week first episode receive least 10day course standard antibiotic therapy . Patient exclusion criterion 1 . Planned actively participate another clinical trial . 2 . Patients neutropenia absolute neutrophil count &lt; 0.5 x 109/L 3 . Evidence toxic megacolon gastrointestinal perforation abdominal xray 4 . Peripheral white blood cell count &gt; 30.0 x 10E9/L AND temperature &gt; 38.0 oC 5 . Active gastroenteritis due Salmonella , Shigella , E. coli 0157H7 , Yersinia Campylobacter . 6 . Presence colostomy 7 . Unable tolerate HBT enema reason . 8 . Requiring systemic antibiotic therapy 7 day . 9 . Actively take Saccharomyces boulardii 10 . Severe underlying disease patient expect survive least 30 day . 11 . Any condition , opinion investigator , treatment may pose health risk subject . Donor inclusion 1 . Able provide sign inform consent . 2 . Able complete sign donor questionnaire 3 . Able adhere fecal transplantation stool collection standard operate procedure . Donor exclusion 1 . Tested positive following : Human Immunodeficiency virus ( HIV ) 1/2 , hepatitis IgM , hepatitis B ( HBsAg ) , hepatitis C antibody , syphilis , human T lymphotrophic virus ( HTLV ) 1/II vancomycin resistant Enterococcus ( VRE ) , methicillin resistant S. aureus ( MRSA ) , Salmonella , Shigella , E.coli O157 H7 , Yersinia Campylobacter . 2 . Detection ovum , parasites , C. difficile toxin , norovirus , adenovirus , rotavirus stool examination 3 . History type active cancer autoimmune disease 4 . History risk factor acquisition HIV , syphilis , Hepatitis B , Hepatitis C , prion neurological disease determine donor questionnaire , appendix B . 5 . History gastrointestinal comorbidities , e.g. , inflammatory bowel disease , irritable bowel syndrome , chronic constipation diarrhea 6 . Receipt blood transfusion country Canada precede 6 month 7 . Antibiotic use systemic immunosuppressive agent 3 month prior stool donation 8 . Receipt type live vaccine within 3 month prior stool donation 9 . Ingestion nut shell fish 3 day precede donation recipient know allergy food . 10 . Any current previous medical psychosocial condition behaviour opinion investigator may pose risk recipient donor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Randomized</keyword>
	<keyword>Double Blind</keyword>
	<keyword>Fecal Transplant</keyword>
	<keyword>Recurrent</keyword>
	<keyword>Clostridium difficile infection</keyword>
	<keyword>CDI</keyword>
	<keyword>HBT</keyword>
	<keyword>Diarrhea</keyword>
	<keyword>Frozen HBT</keyword>
	<keyword>Thawed HBT</keyword>
	<keyword>Fecal Enema</keyword>
</DOC>